Ma. Ricci Gomez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ma. Ricci Gomez has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Deepna Balakrishnan
Tumor Immunology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia
15 shared publications - Greg Kelly
Conjoint Gastroenterology Laboratory, QIMR Berghofer Medical Research Institute, Herston Rd, Herston, QLD 4006, Australia
15 shared publications - Philippe Krebs
Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland
15 shared publications - Rajiv Khanna
QIMR Berghofer Medical Research Institute
15 shared publications - Rebecca Joyce Johnston
QIMR Berghofer Medical Research Institute, Brisbane, Australia
15 shared publications - Shachi Rana
Tumor Immunology Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia
15 shared publications
Latest Publications
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
Table S2A: Differential expression analysis results for naive Fcer1g KO vs naive WT spleen-derived NK cells at FDR. Table S2B: Reactome enrichment analysis results for significantly up-regulated genes in naive Fcer1g KO vs naive WT spleen-derived NK cells. Table S2C: Reactome enrichment analysis results for significantly down-regulated genes in naive Fcer1g KO vs naive WT spleen-derived NK cells. Table S2D: Differential expression analysis results for Fcer1g KO vs WT NK cells isolated from tumour-bearing lungs at FDR < 0.05. Table S2E: Reactome enrichment analysis results for significantly up-regulated genes in Fcer1g KO vs WT NK cells isolated from tumour-bearing lungs. Table S2F: Reactome enrichment analysis results for significantly down-regulated genes in Fcer1g KO vs WT NK cells isolated from tumour-bearing lungs. Table S2G: Differential expression analysis results for IL-15-treated Fcer1g KO vs IL-15-treated WT spleen-derived NK cells at FDR < 0.05.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
Table S2A: Differential expression analysis results for naive Fcer1g KO vs naive WT spleen-derived NK cells at FDR. Table S2B: Reactome enrichment analysis results for significantly up-regulated genes in naive Fcer1g KO vs naive WT spleen-derived NK cells. Table S2C: Reactome enrichment analysis results for significantly down-regulated genes in naive Fcer1g KO vs naive WT spleen-derived NK cells. Table S2D: Differential expression analysis results for Fcer1g KO vs WT NK cells isolated from tumour-bearing lungs at FDR < 0.05. Table S2E: Reactome enrichment analysis results for significantly up-regulated genes in Fcer1g KO vs WT NK cells isolated from tumour-bearing lungs. Table S2F: Reactome enrichment analysis results for significantly down-regulated genes in Fcer1g KO vs WT NK cells isolated from tumour-bearing lungs. Table S2G: Differential expression analysis results for IL-15-treated Fcer1g KO vs IL-15-treated WT spleen-derived NK cells at FDR < 0.05.
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
Functional impact of CD244 blockade on NK cell development and maturation
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
Functional impact of CD244 blockade on NK cell development and maturation
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S10 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
Effect of IL-15 on surface receptor expression on FcRγ-deficient NK cells
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S10 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
Effect of IL-15 on surface receptor expression on FcRγ-deficient NK cells
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
CD244 expression across splenic immune cell populations
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
CD244 expression across splenic immune cell populations
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
Table S3: Proteins with a statistically significant fold change of at least 1.5 between Fcer1g KO and WT samples where both conditions had CVs of >30%.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
Table S3: Proteins with a statistically significant fold change of at least 1.5 between Fcer1g KO and WT samples where both conditions had CVs of >30%.
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
FcRγ is essential for NK cell-mediated tumour control and effector function in vivo
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
FcRγ is essential for NK cell-mediated tumour control and effector function in vivo
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S9 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
In vitro and in vivo cytokine-mediated rescue of FcRγ-deficient NK cell dysfunction
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S9 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
In vitro and in vivo cytokine-mediated rescue of FcRγ-deficient NK cell dysfunction
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
Impact of FcRγ and CD244 on NK cell conjugate formation
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
Impact of FcRγ and CD244 on NK cell conjugate formation
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
Transcriptomic and pathway analysis of lung-infiltrating FcRγ-deficient NK cells in tumour-bearing mice
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
Transcriptomic and pathway analysis of lung-infiltrating FcRγ-deficient NK cells in tumour-bearing mice